Life Sciences
Moderna's Rally Is Not Over: Our Latest Trading Strategy
Thursday's rally was sparked by news that Moderna's Covid-19 vaccine candidate is moving to Phase II testing.
Alexandria Real Estate Equities Offers Yield and a Modest Upside Target
The charts and indicators of ARE are heading in the right direction but not with convincing volume.
Agilent Technologies Could Regain Its Former Peak
CEO McMullen said it's not a matter of if they'll have a vaccine, but when.
GlaxoSmithKline Charts Prescribe Positive Outlook as It Chases Covid-19 Vaccine
The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.
This Dividend Aristocrat Should Keep Your Portfolio Healthy
With a strong history in an important industry, Becton Dickinson looks set to provide and increase its dividend through this crisis and beyond.
Go Long Veeva Systems on Strength as the Rally Could Extend Further
The technical signals for the technology provider to the life science industry show its shares have upside potential.
Licking Our Wounds and Waiting to See How the Covid-19 Story Plays Out
The next four to six weeks could determine whether the U.S. economy can recover from the coronavirus crisis without lasting damage
Thermo Fisher Scientific's Covid-19 Test Could Help It Test Higher Ground
The pace of the selloff in shares of the maker of lab equipment has begun to slow and that is a positive.
3M Needs to Form a Lengthy Base Before It Is Attractive Again
The technology giant has been in bearish mode for quite some time and likely will need to rebase before the coast is clear to buy it.
Stryker Shares Could Continue to Struggle in the Weeks Ahead
The stock of the medical device maker has been stagnant for months and its charts have yet to prove themselves.